Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. DSX
2. GNK
3. INTC
4. SPCX
5. ACN
6. III
7. SAN
8. TTEC
9. SNY
10. DAL

Go back to Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting
(NASDAQ: RZLT) Delayed: 5.02 +0.23 (4.80%)
Previous Close $4.79    52 Week High $ 
Open $4.84    52 Week Low $ 
Day High $5.16    P/E N/A 
Day Low $4.84    EPS $ 
Volume 2,812,694